Diseases That Requiring Cardiopulmonary Rehabilitation in Adult and Geriatric Individuals

Abstract

Cardiopulmonary rehabilitation is comprehensive treatment approaches which are including prevention of cardiovascular and respiratory system diseases, reduction of symptoms associated with disease, and lifestyle changes following the disease. Cardiovascular system diseases such as coronary artery diseases, heart failure, peripheral vascular diseases, lymphedema, hypertension, metabolic syndrome, obesity, diabetes mellitus and respiratory system diseases such as chronic obstructive pulmonary disease (COPD), bronchiectasis, asthma, pulmonary hypertension, cor pulmonale, pulmonary embolism and interstitial lung diseases are requires cardiopulmonary rehabilitation for adult individuals. Geriatric individuals are the target population of cardiovascular and respiratory system diseases due to the changes caused by aging. While these changes increase the use of health services in geriatric individuals, they also reveal the need for cardiopulmonary rehabilitation. In this review, diseases associated with cardiopulmonary rehabilitation were selected and examined. The features of cardiovascular and respiratory system diseases, which are common in adults and geriatric individuals, that require cardiopulmonary rehabilitation are mentioned. As a result, it has been observed that the need for cardiopulmonary rehabilitation is caused by a large number of diseases in adult and geriatric individuals. In these populations, cardiopulmonary rehabilitation has played a substantial role in the treatment of diseases in terms of its health benefits.

Keywords

• Cardiopulmonary rehabilitation
• cardiovascular diseases
• respiratory diseases
• aging

Erişkin ve Geriatrik Bireylerde Kardiyopulmoner Rehabilitasyon Gerektiren Hastalıklar

Abstract

Kardiyopulmoner rehabilitasyon; kardiyovasküler ve respiratuar sistem hastalıklarının önlenmesi, hastalıklarla ilişkili semptomların azaltılması ve hastalığın ardından yaşam biçimi değişikliklerini içeren kapsamlı tedavi yaklaşımlarından oluşmaktadır. Erişkin bireylerde kardiyopulmoner rehabilitasyon gerektiren koroner arter hastalıkları, kalp yetersizliği, periferik damar hastalıkları, lenf ödem, hipertansiyon, metabolik sendrom ve obezite, diabetes mellitus gibi kardiyovasküler sistem hastalıkları ve kronik obstrüktif akciğer hastalığı (KOAH), bronşektazi, astım, pulmoner hipertansiyon, kor pulmonale, pulmoner emboli ve interstisyel akciğer hastalıkları gibi respiratuar sistem hastalıkları söz konusudur. Geriatrik bireyler ise yaşlanmanın meydana getirdiği değişimlerle kardiyovasküler ve respiratuar sistem hastalıklarının hedef popülasyonu halindedir. Meydana gelen bu değişimler geriatrik bireylerde sağlık hizmetlerinin kullanımını arttırırken kardiyopulmoner rehabilitasyona duyulan gereksinimi de ortaya çıkarmaktadır. Bu derlemede erişkin ve geriatrik bireylerde kardiyopulmoner rehabilitasyonla ilişkili hastalıklar seçilerek incelenmiştir. Erişkin ve geriatrik bireylerde yaygın görülen kardiyovasküler ve respiratuar sistem hastalıklarının kardiyopulmoner rehabilitasyon ihtiyacı doğuran özelliklerinden bahsedilmektedir. Sonuç olarak kardiyopulmoner rehabilitasyona duyulan ihtiyacın erişkin ve geriatrik bireylerde oldukça fazla sayıda hastalıktan kaynaklandığı görülmüştür. Bu popülasyonlarda kardiyopulmoner rehabilitasyon sağlıkla ilgili kazandırdığı faydalar açısından hastalıkların tedavisinde azımsanmayacak roller üstlenmiştir.

Keywords

• Kardiyopulmoner rehabilitasyon
• kardiyovasküler hastalıklar
• respiratuar hastalıklar
• yaşlanma

References

1. Alpsoy Ş (2020) Exercise and hypertension. Adv Exp Med Biol 1228:153-67.
2. Anderson L, Thompson DR, Oldridge N, Zwisler AD, Rees K, Martin N, Taylor RS (2016) Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2016:CD001800.
3. Arıkan H (2016) Kardiyopulmoner rehabilitasyon. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 277-85.
4. Armstrong M, Vogiatzis I (2019) Personalized exercise training in chronic lung diseases. Respirology 24:854-62.
5. Barnes PJ (2019) Pulmonary diseases and ageing. Subcell Biochem 91:45-74.
6. Beksaç B (2019) Tromboemboli profilaksisinde mekanik yöntemler. TOTBİD Dergisi 18:486-88.
7. Benjamin N, Marra AM, Eichstaedt C, Grünig E (2018) Exercise training and rehabilitation in pulmonary hypertension. Heart Fail Clin 14:425-30.
8. Blair M (2016) Diabetes mellitus review. Urol Nur 36:27-36.

9. Bolluk AÇ, Özçakar N (2019) Yaşlılarda kardiyovasküler sistem hastalıklarına yaklaşım. Turkiye Klinikleri J Fam Med-Special Topics 10:69-75.
10. Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ (2019) Peripheral artery disease: past, present, and future. Am J Med 132:1133-41.
11. Cattadori G, Segurini C, Picozzi A, Padeletti L, Anzà C (2018) Exercise and heart failure: an update. ESC Heart Fail 5:222-32.
12. Colberg SR, Sigal RJ, Yardley JE, Riddell MC, Dunstan DW, Dempsey PC, ... Tate DF (2016) Physical activity/exercise and diabetes: a position statement of the american diabetes association. Diabetes Care 39:2065-79.
13. Conte SM, Vale PR (2018) Peripheral arterial disease. Heart Lung Circ 27:427-32.
14. Costantino S, Paneni F, Cosentino F (2016) Ageing, metabolism and cardiovascular disease. J Physiol 594:2061-73.
15. Çırak Y, Karahan Z (2016) Periferik damar hastalıkları rehabilitasyonu. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 443-65.
16. Dayan JH, Ly CL, Kataru RP, Mehrara BJ (2018) Lymphedema: pathogenesis and novel therapies. Annu Rev Med 69:263-76.
17. Demir R (2016) Pulmoner hipertansiyonda kardiyopulmoner rehabilitasyon. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 467-74.
18. Demirağ F (2019) İnterstisyel akciğer hastalıklarında güncel gelişmeler. J Curr Pathol 3:117-28.
19. Demirtaş RN, Özel CB, Arıkan H (2016) Metabolik sendrom, obezite ve kardiyopulmoner rehabilitasyonu. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 423-42.
20. Dingwall H, Ferrier K, Semple J (2006) Exercise prescription in cardiac rehabilitation. In: Thow MK (ed) Exercise leadership in cardiac rehabilitation. England, pp 97-131.
21. Doherty S (2017) Pulmonary embolism: an update. Aust Fam Physician 46:816-20.
22. Düger T, Uysal SA, Kabak VY (2019) Onkolojik fizyoterapi ve rehabilitasyonda egzersizin kanıt düzeyi. Turkiye Klinikleri J Physiother Rehabil-Special Topics 1:71-8.
23. Ergün P (2019) Pulmoner rehabilitasyon güncel yaklaşımlar. Güncel Göğüs Hastalıkları Serisi 7:7-18.
24. Forman DE, Maurer MS, Boyd C, Brindis R, Salive ME, Horne FM, . . . Rich MW (2018) Multimorbidity in older adults with cardiovascular disease. J Am Coll Cardiol 71: 2149-61.
25. Fossmo HL, Holtebekk E, Giltvedt K, Dybesland AR, Sanaker PS, Ørstavik K (2018) Physical exercise in adults with hereditary neuromuscular disease. Tidsskr Nor Laegeforen 138.
26. Garrison DM, Pendela VS, Memon J (2020) Cor pulmonale. In: StatPearls [Internet]. Treasure Island, Florida.
27. Gomes-Neto M, Duraes AR, Reis HFCD, Neves VR, Martinez BP, Carvalho VO (2017) High-intensity interval training versus moderate-intensity continuous training on exercise capacity and quality of life in patients with coronary artery disease: a systematic review and meta-analysis. Eur J Prev Cardiol 24:1696-707.
28. Grada AA, Phillips TJ (2017) Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol 77:1009-20.
29. Güven F, Kantarcı M (2018) Miyokard perfüzyonu ve iskemik kalp hastalıkları. Trd Sem 6:152-69.
30. Haykowsky MJ, Daniel KM, Bhella PS, Sarma S, Kitzman DW (2016) Heart failure: exercise-based cardiac rehabilitation: who, when, and how intense? Can J Cardiol 32:382-7.
31. Heinl RE, Dhindsa DS, Mahlof EN, Schultz WM, Ricketts JC, Varghese T, . . . Sperling L (2016) Comprehensive cardiovascular risk reduction and cardiac rehabilitation in diabetes and the metabolic syndrome. Can J Cardiol 32:349–57.
32. Hodgson CL, Tipping CJ (2017) Physiotherapy management of intensive care unit-acquired weakness. J Physiother 63:4-10.
33. Idorn M, Straten PT (2017) Exercise and cancer: from "healthy" to "therapeutic"? Cancer Immunol Immunother 66:667-71.
34. İnce Dİ (2016) Yoğun bakımda fizyoterapi ve rehabilitasyon. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 527-37.
35. İnkaya BV, Oğuz S (2010) Kardiyak rehabilitasyon. Yoğun Bakım Hemşireliği Dergisi 14:14-9.
36. Jenkins DW, Jenks A (2017) Exercise and diabetes: a narrative review. J Foot Ankle Surg 56:968-74.
37. Karalezli A (2018) Pulmoner emboli. Güncel Göğüs Hastalıkları Serisi 6:16-35.
38. Keskin T, Başkurt F (2020) Yaşlılarda egzersiz kompliyansı ve motivasyon. SDÜ Sağlık Bilimleri Dergisi 11:369-75.
39. Kırdı N, Kocaman AA (2019) Yaşlanma sürecinde ve yaşlılık döneminde egzersizin önemi. Turkiye Klinikleri J Intern Med Nurs-Special Topics 5:32-8.
40. Laddu DR, Ozemek C, Hauer TL, Rouleau CL, Campbell TS, Wilton SB, . . . Arena R (2020) Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes. Int J Cardiol 301:156-62.
41. Lang JE (2019) The impact of exercise on asthma. Curr Opin Allergy Clin Immunol 19:118-25.
42. Mampuya WR (2012) Cardiac rehabilitation past, present and future: an overview. Cardiovasc Diagn Ther 2:38-49.
43. Mary P, Servais L, Vialle R (2018) Neuromuscular diseases: diagnosis and management. Orthop Traumatol Surg Res 104:89-95.
44. McShane PJ, Tino G (2019) Bronchiectasis. Chest 155:825-33.
45. Metra M, Teerlink JR (2017) Heart failure. Lancet 390:1981-95.
46. Myers J, Kokkinos P, Nyelin E (2019) Physical activity, cardiorespiratory fitness, and the metabolic syndrome. Nutrients 11:1652-69.
47. Nakazawa A, Cox NS, Holland AE (2017) Current best practice in rehabilitation in interstitial lung disease. Ther Adv Respir Dis 11:115-28.
48. Nanda A, Wasan AN (2020) Asthma in adults. Med Clin North Am 104:95-108.
49. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, ... & Canada H (2018) Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children. Can J Cardiol 34:506-25.
50. O’Donnell AE (2018) Bronchiectasis update. Curr Opin Infect Dis 31:194-8.
51. Özalp Ö, Arıkan H (2016) Bronşektazi ve rehabilitasyonu. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 357-70.
52. Paley CA, Johnson MI (2018) Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Sci Med Rehabilitation 10:1-8.
53. Savcı S (2016) Kronik obstrüktif akciğer hastalığı ve pulmoner rehabilitasyon. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 343-56.
54. Servey JT, Stephens M (2016) Cardiac rehabilitation: improving function and reducing risk. Am Fam Physician 94:37-43.
55. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, ... & Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1-13.
56. Smit M, Coetzee AR, Lochner A (2019) The pathophysiology of myocardial ischemia and perioperative myocardial infarction. J Cardiothorac Vasc Anesth 34:2501-12.
57. Smith MP (2017) Diagnosis and management of bronchiectasis. CMAJ 189:E828-E835.
58. Souza R (2019) Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 53:1-13.
59. Şener EE, Daldal İ (2019) Venöz tromboembolizm tanımı ve fizyopatolojisi. TOTBİD Dergisi 18:469-73.
60. Thomas SG, Marzolini S, Lin E, Nguyen CH, Oh P (2019) Clin Geriatr Med 35:527-37.
61. Troosters T, Blondeel A, Janssens W, Demeyer H (2019) The past, present and future of pulmonary rehabilitation. Respirology 24:830–7.
62. Tzani I, Tsichlaki M, Zerva E, Papathanasiou G, Dimakakos E (2018) Physiotherapeutic rehabilitation of lymphedema: state-of-the-art. Lymphology 51:1-12.
63. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, . . . Desormis I (2018) 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J 39:3021–104.
64. Winzer EB, Woitek F, Linke A (2018) Physical activity in the prevention and treatment of coronary artery disease. J Am Heart Assoc 7:e007725.
65. Ventura HO, Lavie CJ (2018) Hypertension: management and measurements. Curr Opin Cardiol 33:375-6.
66. Yeldan İ, Aslan GK (2016) Nöromusküler hastalıklarda kardiyopulmoner rehabilitasyon. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 383-96.
67. Yıldız A (2016). Farklı fiziksel kapasite gruplarında kişiye özgü egzersiz. Turkiye Klinikleri J Physiother Rehabil-Special Topics 2:40-3.
68. Yurdalan SU (2016) Organ transplantasyonlarında fizyoterapi ve rehabilitasyon. In: Karaduman A, Yılmaz ÖT (ed) Fizyoterapi ve rehabilitasyon cilt 3. Ankara, pp 507-12.
69. Zeng Y, Jiang F, Chen Y, Chen P, Cai S (2018) Exercise assessments and trainings of pulmonary rehabilitation in COPD: a literature review. Int J Chron Obstruct Pulmon Dis 13:2013-23.
70. Zhang W, Song M, Qu J, Liu GH. (2018). Epigenetic modifications in cardiovascular aging and diseases. Circ Res 123:773-86.